story of the week
Febrile Neutropenia Risk With TCH(P) in HER2+ Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer
Breast Cancer Res Treat 2021 Dec 01;190(3)357-372, H Van Belle, SA Hurvitz, PJ Gilbar, H WildiersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.